Measles and rubella immunity in the population of Bhutan, 2017

Vaccine. 2019 Oct 8;37(43):6463-6469. doi: 10.1016/j.vaccine.2019.08.085. Epub 2019 Sep 6.

Abstract

Background: In 2017, measles elimination was verified in Bhutan, and the country appears to have sufficiently high vaccination coverage to achieve rubella elimination. However, a measles and rubella serosurvey was conducted to find if any hidden immunity gaps existed that could threaten Bhutan's elimination status.

Methods: A nationwide, three-stage, cluster seroprevalence survey was conducted among individuals aged 1-4, 5-17, and >20 years in 2017. Demographic information and children's vaccination history were collected, and a blood specimen was drawn. Serum was tested for measles and rubella immunoglobulin G (IgG). Frequencies, weighted proportions, and prevalence ratios for measles and rubella seropositivity were calculated by demographic and vaccination history, taking into account the study design.

Results: Of the 1325 individuals tested, 1045 (81%, 95% CI 78%-85%) were measles IgG seropositive, and 1290 (97%, 95% CI 95%-99%) were rubella IgG seropositive. Rubella IgG seropositivity was high in all three age strata, but only 47% of those aged 5-17 years were measles IgG seropositive. Additionally, only 41% of those aged 5-17 years who had documented receipt of two doses of measles- or measles-rubella-containing vaccine were seropositive for measles IgG, but almost all these children were rubella IgG seropositive.

Conclusions: An unexpected measles immunity gap was identified among children 5-17 years of age. It is unclear why this immunity gap exists; however, it could have led to a large outbreak and threatened sustaining of measles elimination in Bhutan. Based on this finding, a mass vaccination campaign was conducted to close the immunity gap.

Keywords: Bhutan; Measles; Rubella; Seroprevalence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Bhutan
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Disease Eradication
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Infant
  • Male
  • Measles / immunology*
  • Measles / prevention & control*
  • Measles Vaccine / immunology
  • Rubella / immunology*
  • Rubella / prevention & control*
  • Rubella Vaccine / immunology
  • Seroepidemiologic Studies
  • Vaccination / statistics & numerical data
  • Young Adult

Substances

  • Immunoglobulin G
  • Measles Vaccine
  • Rubella Vaccine